A new type of liposomal liver-specific contrast medium was studied in an experimental tumour model. Rabbits were inoculated with VX2-carcinoma directly into the liver at laparotomy. CT studies were carried out 14 days after inoculation. The liver-specific contrast medium consisted of a suspension of liposomes in a 100 mg I/ml iodixanol solution, with equal amounts of encapsulated and nonencapsulated iodixanol. It was administered at a dose of 200 mg I/kg. The contrast of normal liver tissue to tumorous tissue was significantly increased by contrast medium administration, the increase being largest 10 min after injection.
BurgenerA.: Contrast agents for computed tomography. In:Contrast enhancement in body computerized tomography. 11th International Symposium, Bern 1981, p. 5. Edited by FuchsW. A.. Thieme Stratton Inc., New York1981.
5.
BurgenerF. A.HamlinD. J.: Contrast enhancement of hepatic tumors in CT. Comparison between bolus and infusion techniques. AJR140 (1981), 291.
6.
ChengK. T.SeltzerS. E.AdamsD. F.BlauM.: The production and evaluation of contrast-carrying liposomes made with an automatic high-pressure system. Invest. Radiol.22 (1987), 47.
7.
CoxI. H.FoleyW. D.HoffmanR. G.: Right window for dynamic hepatic CT. Radiology181 (1991), 18.
IvancevK.LunderquistA.McCuskeyR.McCuskeyP.WretlindA.: Experimental investigation of a new iodinated lipid emulsion for computed tomography of the liver. Acta Radiol.30 (1989), 1.
10.
IvancevK.LunderquistA.McCuskeyR.McCuskeyP.WretlindA.: Effect of intravenously injected iodinated lipid emulsions on the liver — An experimental study correlating computed tomography findings with in vivo microscopy and electron microscopy findings. Acta Radiol.30 (1989), 291.
11.
JanoffA. S.MincheyS. R.PerkinsW. R.: Interdigitation-fusion vesicles. A new approach for selective opacification of the RES. Invest. Radiol.26 (1991), S167.
12.
LeanderP.GolmanK.StrandeP.KlavenessJ.BesjakovJ.FältK.: A comparison between IEEC, a new biodegradable particulate contrast medium, and iohexol in a tumor model of computed tomography of the liver. Invest. Radiol.28 (1993), 513.
13.
Lopez-BeresteinG.KasiL.RossenblumM. G.: Clinical pharmacology of 99mTc-labelled liposomes in patients with cancer. Cancer Res.44 (1984), 375.
14.
MillerD. L.SimmonsJ. T.ChangR.: Hepatic metastases detection. Comparison of three CT contrast enhancement methods. Radiology165 (1987), 785.
RyanP. J.DavisM. A.DeGaetaL. R.WodaB.MelchiorD. L.: Liposomes loaded with contrast material for image enhancement in computed tomography. Radiology152 (1984), 759.
18.
SachseA.LeikeJ. U.RösslingG. L.WagnerS. E.KrauseW.: Preparation and evaluation of lyophilized iopromide-carrying liposomes for liver tumor detection. Invest. Radiol.28 (1993), 838.
SeltzerS. E.GregoriadisG.DickR.: Evaluation of the dehydration-rehydration method for production of contrast-carrying liposomes. Invest. Radiol.23 (1988), 131.
21.
SheedyP. F.StephensD. H.HatteryR. R.MuhmJ. R.HartmanG. W.: Computed tomography of the body. Initial clinical trial with the EMI prototype. AJR127 (1978), 23.
22.
ViolanteM. R.DeanP. B.: Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography. Radiology134 (1980), 237.
23.
ViolanteM. R.FischerH. W.: Particulate suspensions of contrast media. In:Radiocontrast agents. Edited by SovakM.. Springer-Verlag, New York1984.
24.
ZemanR. K.ClementsL. A.SilvermanP. M.: CT of the liver. A survey of prevailing methods for administration of contrast material. AJR150 (1988), 107.
